R E T U R N M E N U |
Dietary Lycopene
and Plasma/Serum Lycopene |
C R I T I C A L F I N D I N G S |
|
CANCER
Lycopene Supplementation and Disease Risk
Cancer- main findings
- Represented cancer studies: Prostate (n=19), Colorectal (n=2), Breast (n=2), Brain (n=1), Lung (n=1).
- Lycopene supplementation appears to be safe and well tolerated for up to 1 year; however, limited evidence for improving disease status.
Summary of studies and outcomes
- Number of studies = 25
- Risk estimates (RE) = 27
- (-) = 11
- N = 17
- Risk estimates by Tomato or Lycopene category
- √GT G. Tom =
- √PT P. Tom =
- √F F Tom =
- √Lyco Lyco = 11 (-), 17 (N)